drugset / Trial / NCT00045123
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
RandomizedDouble-blindTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. R-flurbiprofen may be effective in delaying the recurrence of localized prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of R-flurbiprofen in treating patients who have localized prostate cancer at risk of recurrence following radiation therapy and/or prostatectomy.
Timeline
- Start
- 2002-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tarenflurbil | Small molecule | — | Oral |